Brief: IceCure Submits FDA Regulatory Filing For New XSense Cryoablation System With Cryoprobes
02/04/2024 15:35
April 2 (Reuters) - IceCure Medical Ltd ICCM.O :
* ICECURE SUBMITS FDA REGULATORY FILING FOR NEW XSENSE™
CRYOABLATION SYSTEM WITH CRYOPROBES
* ICECURE MEDICAL LTD - FILED A 510(K) SUBMISSION WITH US
FDA FOR
CLEARANCE OF ITS SINGLE PROBE CRYOABLATION SYSTEM
Source text for Eikon: ID:nPn3fyXTza
Further company coverage: ICCM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Icecure Medical
See all newsIcecure Medical Ltd reports results for the quarter ended June 30 - Earnings Summary
Israel's IceCure Medical H1 revenue rises on higher system, probe sales
Brief: Icecure Sio Petitions Nccn To Include Cryoablation In Breast Cancer Treatment Guidelines, Citing Icecure's FDA Clearance Of Prosense®
NASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:45 AM